PEPTIDEREPORT

Primary regulatory

MK-677 Hip Fracture Recovery Trial: ClinicalTrials.gov

ClinicalTrials.gov registry entry (NCT01016781) for the MK-677 hip fracture recovery trial sponsored by Merck. MK-677 is not FDA-approved for any indication.

ClinicalTrials.gov / U.S. National Library of MedicinePublished 2009-11-01Accessed 2026-07-01

Open original source

Registry record

Source metadata

Publisher
ClinicalTrials.gov / U.S. National Library of Medicine
Source type
Primary regulatory
Registry ID
clinicaltrials-gov-mk677-hip-fracture

Source usage

Linked from 5 pages

Compound

MK-677 (Ibutamoren)

Comparison

MK-677 vs Ipamorelin

Evidence curation

Best Peptides for Growth Hormone Release

Guide

Peptide Category Explainers: How Every Compound Class on This Site Is Defined

Guide

Peptide Half-Life Reference Table

Interpretation boundary

What this record can and cannot establish

Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.